Document Detail

Regulation of myocardial fibrosis by MicroRNAs.
MedLine Citation:
PMID:  20625314     Owner:  NLM     Status:  In-Process    
Interstitial and perivascular fibrosis is a hallmark of adverse cardiac remodeling in response to stress such as hypertension, valve disease, or myocardial infarction. The cross talk between fibroblasts and cardiomyocytes seems to be a major determinant of the hypertrophic response, and fibroblasts may prove to be essential regulators of cardiac remodeling. The present review summarizes current knowledge on the modulation of myocardial fibrosis by microRNAs (miRNAs), single-stranded molecules consisting of approximately 22 noncoding nucleotides that regulate a variety of target genes involved in cardiovascular (patho)physiology. Dissection of miRNA-mediated mechanisms on myocardial and cellular and subcellular levels will provide insights into the impact of miRNAs for cardiac structural changes induced by different stressors and also expand our understanding of the interdependence of different cell types in the heart with regard to extracellular matrix formation during healing and remodeling after myocardial infarction or in response to pressure overload. The first successful treatment of fibrosis and failure in a murine pressure overload model by application of miRNA antagonists such as antagomirs in vivo raises the hope that manipulating miRNAs may emerge as a novel treatment strategy for fibrotic changes not only in the heart but also in other organs.
Johann Bauersachs
Related Documents :
12087064 - Ligands of the peroxisome proliferator-activated receptors (ppar-gamma and ppar-alpha) ...
1836094 - Progressive ventricular dilation in experimental myocardial infarction and its attenuat...
20922534 - A novel phenylpyridazinone, t-3999, reduces the progression of autoimmune myocarditis t...
19687354 - Increased expression of integrin-linked kinase attenuates left ventricular remodeling a...
1280744 - Effect of therapeutic dopamine administration on myocardial catecholamine and neuropept...
12559334 - Aortic arch reconstruction using regional perfusion without circulatory arrest.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  56     ISSN:  1533-4023     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  454-9     Citation Subset:  IM    
Medizinische Klinik und Poliklinik I, Universitätsklinikum, Julius-Maximilians-Universität, Würzburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Inhibition of secretory phospholipase A2 activity attenuates acute cardiogenic pulmonary edema induc...
Next Document:  Endothelin-1 stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by endothel...